| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Exact Sciences Corporation (NASDAQ: EXAS)
EXAS Technical Analysis
5
| As on 9th Jun 2023 EXAS SHARE Price closed @ 87.81 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 53.54 & Strong Buy for SHORT-TERM with Stoploss of 75.92 we also expect STOCK to react on Following IMPORTANT LEVELS. |
EXASSHARE Price
| Open | 90.51 | Change | Price | % |
| High | 90.87 | 1 Day | -2.84 | -3.13 |
| Low | 87.73 | 1 Week | 6.23 | 7.64 |
| Close | 87.81 | 1 Month | 24.37 | 38.41 |
| Volume | 1958148 | 1 Year | 5.41 | 6.57 |
| 52 Week High 87.76 | 52 Week Low 30.35 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| EXAS Daily Charts |
EXAS Intraday Charts |
Whats New @ Bazaartrend |
EXAS Free Analysis |
|
|
EXAS Important Levels Intraday
| RESISTANCE | 93.86 |
| RESISTANCE | 91.92 |
| RESISTANCE | 90.72 |
| RESISTANCE | 89.52 |
| SUPPORT | 86.10 |
| SUPPORT | 84.90 |
| SUPPORT | 83.70 |
| SUPPORT | 81.76 |
EXAS Forecast April 2024
| 4th UP Forecast | 121.84 |
| 3rd UP Forecast | 110.93 |
| 2nd UP Forecast | 104.18 |
| 1st UP Forecast | 97.43 |
| 1st DOWN Forecast | 78.19 |
| 2nd DOWN Forecast | 71.44 |
| 3rd DOWN Forecast | 64.69 |
| 4th DOWN Forecast | 53.78 |
EXAS Weekly Forecast
| 4th UP Forecast | 108.74 |
| 3rd UP Forecast | 102.03 |
| 2nd UP Forecast | 97.88 |
| 1st UP Forecast | 93.73 |
| 1st DOWN Forecast | 81.89 |
| 2nd DOWN Forecast | 77.74 |
| 3rd DOWN Forecast | 73.59 |
| 4th DOWN Forecast | 66.88 |
EXAS Forecast2024
| 4th UP Forecast | 207.13 |
| 3rd UP Forecast | 168.86 |
| 2nd UP Forecast | 145.21 |
| 1st UP Forecast | 121.56 |
| 1st DOWN Forecast | 54.06 |
| 2nd DOWN Forecast | 30.41 |
| 3rd DOWN Forecast | 6.76 |
| 4th DOWN Forecast | -31.51 |
Exact Sciences Corporation ( NASDAQ USA Symbol : EXAS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
EXAS Business Profile
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype MAP, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin. Address: 5505 Endeavor Lane, Madison, WI, United States, 53719
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service